Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry
- PMID: 3881999
- DOI: 10.1176/ajp.142.2.155
Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry
Abstract
The Task Force examines the present status of studies investigating the relationship between blood plasma concentrations of tricyclic antidepressants and clinical outcome. It discusses some of the discrepancies that have developed among various antidepressant drugs and evaluates the clinical implications of the current status of blood level monitoring. The Task Force concludes that plasma level measurements of imipramine, desmethylimipramine, and nortriptyline are unequivocally clinically useful in certain situations, that these measurements are helpful in many situations, and that plasma level measurements are likely to grow in usefulness.
Similar articles
-
Plasma concentrations of tricyclic antidepressants in clinical practice.J Clin Psychiatry. 1982 Feb;43(2):66-9. J Clin Psychiatry. 1982. PMID: 7056706
-
The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.Am J Psychiatry. 1980 Jun;137(6):653-62. doi: 10.1176/ajp.137.6.653. Am J Psychiatry. 1980. PMID: 6990798 Review.
-
Tricyclic-resistant depression: treatment resistance or inadequate treatment?J Clin Psychiatry. 1985 Oct;46(10):412-7. J Clin Psychiatry. 1985. PMID: 3900051 Review.
-
Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.Neuropsychobiology. 1982;8(2):73-85. doi: 10.1159/000117880. Neuropsychobiology. 1982. PMID: 7070646
-
Plasma concentrations of tricyclic antidepressants in clinical practice.J Clin Psychiatry. 1982 Sep;43(9):389-90. J Clin Psychiatry. 1982. PMID: 7118847 No abstract available.
Cited by
-
"There is no dose-response relationship in psychopharmacotherapy" vs "pharmacotherapy in psychiatry is based on ligand-receptor interaction": a unifying hypothesis and the need for plasma concentration based clinical trials.Psychopharmacology (Berl). 2011 Sep;217(2):297-300. doi: 10.1007/s00213-011-2319-z. Epub 2011 May 4. Psychopharmacology (Berl). 2011. PMID: 21537937 No abstract available.
-
Pharmacokinetic optimisation of the treatment of psychosis.Clin Pharmacokinet. 1993 Sep;25(3):217-36. doi: 10.2165/00003088-199325030-00005. Clin Pharmacokinet. 1993. PMID: 7900948 Review.
-
Monitoring tricyclic antidepressant therapy.Pharmacoeconomics. 1992 Feb;1(2):148-50. doi: 10.2165/00019053-199201020-00012. Pharmacoeconomics. 1992. PMID: 10147108 No abstract available.
-
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.Dialogues Clin Neurosci. 2005;7(3):231-47. doi: 10.31887/DCNS.2005.7.3/pbaumann. Dialogues Clin Neurosci. 2005. PMID: 16156382 Free PMC article.
-
Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.Clin Pharmacokinet. 1993 Feb;24(2):141-60. doi: 10.2165/00003088-199324020-00004. Clin Pharmacokinet. 1993. PMID: 8471078 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources